About

Publications While At HealthPartners

selected publications

Journal Article

A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project. 

Diabetology & Metabolic Syndrome. 2009

One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. 

Diabetes care. 2009

Consensus report of the coalition for clinical research-self-monitoring of blood glucose. 

Journal of Diabetes Science and Technology. 2008

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. 

Lancet (London, England). 2008

Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study. 

Diabetes care. 2006

Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco. 

Diabetes Educator. 2006

Thiazolidinediones: the case for early use. 

Diabetes care. 2006

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. 

Diabetes care. 2005

Accuracy and utility of a 10-test disk blood glucose meter. 

Diabetes Research and Clinical Practice. 2005

Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus. 

Coronary Artery Disease. 2005

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. 

Diabetes care. 2005

Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control. 

Diabetes Technology & Therapeutics. 2005

Review: insulin monotherapy and insulin combined with oral hypoglycemic agents provide similar glycemic control. 

ACP Journal Club. 2005

Review: short-acting insulin analogues reduce glycosylated hemoglobin more than regular human insulin but only in adults with type 1 diabetes. 

ACP Journal Club. 2005

The dyslipidemia of diabetes mellitus: giving triglycerides and high-density lipoprotein cholesterol a higher priority?. 

Endocrinology and Metabolism Clinics of North America. 2005

Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes. 

Current Medical Research and Opinion. 2004

Undetected, uncontrolled blood pressure in type 2 diabetes: self-monitored blood pressure profiles. 

Blood Pressure. 2004

Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self-monitored blood pressure. 

Diabetic Medicine. 2003

Clinical impact of prandial state, exercise, and site preparation on the equivalence of alternative-site blood glucose testing. 

Diabetes care. 2003

The insulin resistance syndrome and coronary artery disease. 

Coronary Artery Disease. 2003

Review

Type 2 diabetes: assessing the relative risks and benefits of glucose-lowering medications [review]. 

American Journal of Medicine. 2010

Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use [review]. 

European Journal of Internal Medicine. 2009

Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use [review]. 

American Journal of Medicine. 2009

Exenatide once weekly for the treatment of type 2 diabetes [review]. 

Expert opinion on investigational drugs. 2009

Comprehensive management of patients with type 2 diabetes: establishing priorities of care [review]. 

American Journal of Managed Care. 2001

Contact

full name

D. M. Kendall

Quick Info

 

Collaboration

Co-author network

Map of science